UK markets closed

Ironwood Pharmaceuticals, Inc. (IRWD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.92+0.32 (+4.21%)
At close: 04:00PM EDT
8.10 +0.18 (+2.27%)
After hours: 05:51PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
442,735
442,735
410,596
413,753
389,523
Cost of revenue
-
-
0
0
3,136
Gross profit
-
-
410,596
413,753
386,387
Operating expenses
Research development
116,085
116,085
44,265
70,405
88,062
Selling general and administrative
158,314
158,314
115,994
111,133
140,003
Total operating expenses
274,399
274,399
160,259
181,538
228,065
Operating income or loss
168,336
168,336
250,337
232,215
158,322
Interest expense
21,629
21,629
7,598
31,150
29,478
Total other income/expenses net
-1,113,747
-1,113,747
182
-1,134
-21,487
Income before tax
-948,069
-948,069
252,422
200,657
108,861
Income tax expense
83,490
83,490
77,357
-327,791
2,685
Income from continuing operations
-1,031,559
-1,031,559
175,065
528,448
106,176
Net income
-1,002,239
-1,002,239
175,065
528,448
106,176
Net income available to common shareholders
-1,002,239
-1,002,239
175,065
528,448
106,176
Basic EPS
-6.14
-
1.13
3.26
0.67
Diluted EPS
-6.18
-
0.96
3.21
0.66
Basic average shares
154,761
-
154,366
162,245
159,427
Diluted average shares
162,864
-
186,312
164,418
160,655